1673-422X
2008 Issue 9
..............page:686
Clusterin: a new therapeutic target for malignancies
liu shi lei ; chen hai quan ; li he cheng
liu shi lei ; chen hai quan ; li he cheng
..............page:671-673
Short and long term clinical outcome of 283 cases of nasopharyngeal carcinoma patients treated with hy-perfractionated radiotherapy
XU Zhi-yuan;LIN Han-xing;ZHANG Xiao-ping;LI Yi-xuan
XU Zhi-yuan;LIN Han-xing;ZHANG Xiao-ping;LI Yi-xuan
..............page:711-713
Oncolytic adenouiruses in combination with chemtherapy in tumor therapy
jiang guan ; liu yan qun ; zheng jun nian
jiang guan ; liu yan qun ; zheng jun nian
..............page:647-650
Clinical significance of distribution of gastrin-releasing peptide receptor in tumors
zhao kai jun ; shen jian kang ; sun qing fang
zhao kai jun ; shen jian kang ; sun qing fang
..............page:660-664
EGFR inhibitors and radiosensitivity of tumor cells
guo qi shuai ; wu yong zhong
guo qi shuai ; wu yong zhong
..............page:680-683
Application of bifidobacterium in cancer gene therapy
sun yue li ; zhao qing yu
sun yue li ; zhao qing yu
..............page:650-653
Cytokines-induced killer cells and neoplasm treatment
xie qiu ; wang jian hua ; niu bo
xie qiu ; wang jian hua ; niu bo
..............page:668-671
New advances in HCC-specific markers
yan tao ; cai jian qiang ; bi xin yu
yan tao ; cai jian qiang ; bi xin yu
..............page:704-707
Research advancement of superparamagnetic iron oxide with magnetic resonance imaging and targeted therapy of tumor angiogenesis
lin bing ying ; zhang jing feng ; zhang min wu
lin bing ying ; zhang jing feng ; zhang min wu
..............page:643-646
Expression and value of Matriptase and HAI-1 in bladder transitional cell carcinoma
ZHOU Zhen-yu;SU Yun;HUXiang-nong;YANG Jian-jun;YAO Mao-yin
ZHOU Zhen-yu;SU Yun;HUXiang-nong;YANG Jian-jun;YAO Mao-yin
..............page:714-718
Research of miRNAs as tumor markers
wang lin ; chang xiao tian
wang lin ; chang xiao tian
..............page:657-660
Malignant tumor-related coagulation disorder and anticoagulation therapy
chang chun xia ; chen hong
chang chun xia ; chen hong
..............page:677-680
Prognostic sigificance of blood coagulation and fibrinolysis disorders in lung cancer
zheng hua ; wang jing ping ; li bao lan
zheng hua ; wang jing ping ; li bao lan
..............page:694-697
Prognostic role of fludeoxyglucose positron emission tomography for non-small-cell lung cancer
li ming huan ; yang guo ren
li ming huan ; yang guo ren
..............page:697-700
Ubiquitin-related protein FAT10 and hepatocellular carcinoma
liu tian de ; yu xin ; shao jiang hua
liu tian de ; yu xin ; shao jiang hua
..............page:700-704
Aromatase inhibitors in neoadjuvant endocrine therapy for breast cancer
wang sheng zuo ; fang mei yu ; ma sheng lin
wang sheng zuo ; fang mei yu ; ma sheng lin
..............page:687-690
Study progress about dendritic/tumor fusion cell-based vaccine in tumor immunotherapy
xie jun ping ; hou xiao hua ; tao xiao nan
xie jun ping ; hou xiao hua ; tao xiao nan
..............page:664-667
Development of hematological test in breast cancer
LI Xiang-dong;SUO Cui-ping
LI Xiang-dong;SUO Cui-ping
..............page:684-686
VEGF, VEGFR and their impact on angiogenesis of hepatocellular carcinoma
jia jin bin ; tang zuo zuo
jia jin bin ; tang zuo zuo
..............page:708-710
Application of PET-CT image fusion in the staging and conformal radiotherapy of esophageal cancer
jia jing hao ; han chun
jia jing hao ; han chun
..............page:690-693
Development of platinum antineoplastic agents
ye rui ping ; yang yang ; chen zhen dong
ye rui ping ; yang yang ; chen zhen dong
..............page:674-677
Role of interstitial fluid pressure in tumor research
li ai ling ; xiu rui juan
li ai ling ; xiu rui juan
..............page:654-657
Concurrent radiotherapy and weekly chemotherapy with low-dose cisplatin and 5-fluorouracil for ad-vanced cervical cancer
JIA Hui;ZHU Zhao-feng;SU Pei-ying
JIA Hui;ZHU Zhao-feng;SU Pei-ying
..............page:718-720